Centre approves Corbevax as precaution dose

by IANS |

New Delhi, Aug 10 (IANS) The Centre on Wednesday approved Biological E's Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin, said a source.

According to the source, the Corbevax vaccine will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines.

Meanwhile, India on Wednesday reported 16,047 new Covid-19 cases in the last 24 hours.

In the same period, there were 54 additional deaths, taking the nationwide death toll to 5,26,826.

Latest News
Slack CEO to quit Salesforce in Jan 2023 Tue, Dec 06, 2022, 01:15 PM
After iPhones, Apple now plans to shift some iPad production to India Tue, Dec 06, 2022, 01:14 PM
Pakistan's Haris Rauf ruled out of Test series v England Tue, Dec 06, 2022, 01:13 PM
Neymar pays tribute to ailing Pele Tue, Dec 06, 2022, 01:12 PM
Brazil cruise past S.Korea 4-1; set up Last 8 clash with Croatia Tue, Dec 06, 2022, 01:10 PM
Tite hails Brazil's 'offensive boldness' Tue, Dec 06, 2022, 01:09 PM
Denmark saw record number of bankruptcies in Nov Tue, Dec 06, 2022, 01:08 PM
Turkish intelligence kills senior YPG member in Syria Tue, Dec 06, 2022, 01:07 PM
Violence, harassment at work affect nearly 23% of people globally: ILO Tue, Dec 06, 2022, 01:05 PM
Sweden's extradition of PKK member shows goodwill: Turkey Tue, Dec 06, 2022, 01:05 PM
Greek businesses, households shift to solar power amid energy crisis Tue, Dec 06, 2022, 01:04 PM
633 migrants rescued off Libyan coast in past week: IOM Tue, Dec 06, 2022, 01:03 PM
Diplomacy, foreign policy contributors honoured at UN with Diwali Foundation award Tue, Dec 06, 2022, 01:02 PM
Miscreants loot cash, jewellery worth Rs 30 lakh in Bihar's Samastipur Tue, Dec 06, 2022, 01:01 PM
'Flying Squad' formed to stop noise pollution in Goa Tue, Dec 06, 2022, 01:00 PM